Approval · Notice of Compliance 7959 · 2006
AROMASIN: Notice of Compliance 7959
Issued May 12, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 7959
- Date
- May 12, 2006
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: adjuvant treatment of early breast cancer
- Therapeutic class
- Aromatase inactivator; anti-tumour agent
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AROMASIN | Not yet assigned | — |
Medicinal ingredients
- EXEMESTANE 25 MG per TAB